{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:41:41Z","timestamp":1793374901343,"version":"4.5.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The presence of pre-formed donor-specific antibodies (DSAs) in kidney transplantation is associated with worse overall outcomes compared with DSA-negative transplantation. A positive complement-dependant cytotoxic crossmatch presents a high immunological risk, while a negative flow cytometry crossmatch is at the lower end of the risk spectrum. Yet, the presence of low-level DSA detected by Luminex alone, that is, positive Luminex and negative flow (PLNF) cytometry crossmatch lacks robust scientific exploration. In this systematic review and pooled analysis, we investigate the glomerular filtration rate, acute rejection (AR), graft survival and patient survival of PLNF transplants compared with DSA-negative transplants. Our analysis identified seven retrospective studies consisting of 429 PLNF transplants and 10\u00a0677 DSA-negative transplants. Pooled analysis identified no significant difference in the incidence of AR at 1\u2009year [relative risk (RR) = 1.35, 95% confidence interval (CI) 0.90\u20132.02, Z\u2009=\u20091.46, P\u2009=\u20090.14, I2 = 0%], graft failure at 1\u2009year (RR = 1.66, 95% CI 0.94\u20132.94, Z\u2009=\u20091.75, P\u2009=\u20090.08, I2 = 23%), graft failure at 5\u2009years (RR = 1.29, 95% CI 0.90\u20131.87, Z\u2009=\u20091.38, P\u2009=\u20090.17, I2 = 0%), patient mortality at 1\u2009year (RR = 0.89, 95% CI 0.31\u20132.56, Z\u2009=\u20090.22, P\u2009=\u20090.82, I2 = 0%) and patient mortality at 5\u2009years (RR = 1.76, 95% CI 0.48\u20136.48, Z\u2009=\u20090.85, P\u2009=\u20090.39, I2 = 61%). Pooled analysis of graft function was not possible due to insufficient data. Current evidence suggests that low-level DSA detected by Luminex alone does not pose significant risk at least in the short\u2013medium term. Considering the shortage of kidney transplants and the ever-increasing waiting time, the avoidance of PLNF transplants may be unwarranted especially in patients who have been enlisted for a long time.<\/jats:p>","DOI":"10.1093\/ndt\/gfy349","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T03:21:45Z","timestamp":1539228105000},"page":"1950-1960","source":"Crossref","is-referenced-by-count":38,"title":["Positive Luminex and negative flow cytometry in kidney transplantation: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"34","author":[{"given":"Jesmar","family":"Buttigieg","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine, Mater Dei Hospital, Malta"},{"name":"Faculty of Health and Life Science, Institute of Learning and Teaching, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Ali","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Science, Institute of Learning and Teaching, University of Liverpool, Liverpool, UK"},{"name":"Department of Renal Medicine, Royal Wolverhampton Hospitals NHS Foundation Trust, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Science, Institute of Learning and Teaching, University of Liverpool, Liverpool, UK"},{"name":"Renal Transplant Unit, Royal Liverpool University Hospital, NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Halawa","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Science, Institute of Learning and Teaching, University of Liverpool, Liverpool, UK"},{"name":"Renal Transplant Unit, Sheffield Teaching Hospitals, NHS Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"2019110402561336900_gfy349-B1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"2019110402561336900_gfy349-B2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"2019110402561336900_gfy349-B3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"2019110402561336900_gfy349-B4","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"2019110402561336900_gfy349-B5","author":"Wells"},{"key":"2019110402561336900_gfy349-B6","year":"2014"},{"key":"2019110402561336900_gfy349-B7","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2019110402561336900_gfy349-B8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1600-6143.2010.03421.x","article-title":"Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy","volume":"11","author":"Willicombe","year":"2011","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0b013e31820794bb","article-title":"Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay","volume":"91","author":"Couzi","year":"2011","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.tp.0000284729.39137.6e","article-title":"Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody","volume":"84","author":"Higgins","year":"2007","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0b013e31822dc38d","article-title":"Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch","volume":"92","author":"Higgins","year":"2011","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B13","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/ajt.13848","article-title":"Clinical significance of pretransplant donor-specific antibodies in the setting of negative cell based flow cytometry crossmatching in kidney transplant recipients","volume":"16","author":"Adebiyi","year":"2016","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1399-3046.2009.01281.x","article-title":"Impaired graft survival in pediatric renal transplant recipients with donor-specific antibodies detected by solid-phase assays","volume":"14","author":"Verghese","year":"2010","journal-title":"Pediatr Transplant"},{"key":"2019110402561336900_gfy349-B15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.humimm.2009.04.018","article-title":"Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival","volume":"70","author":"Vlad","year":"2009","journal-title":"Hum Immunol"},{"key":"2019110402561336900_gfy349-B16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e31816b1c37","article-title":"Pre-transplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?","volume":"85","author":"Gupta","year":"2008","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1600-6143.2007.01944.x","article-title":"Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches","volume":"7","author":"Patel","year":"2007","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B18","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/TP.0b013e3182743cfa","article-title":"Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts","volume":"95","author":"Lawrence","year":"2013","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B21","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.humimm.2009.04.011","article-title":"Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant","volume":"70","author":"Aubert","year":"2009","journal-title":"Hum Immunol"},{"key":"2019110402561336900_gfy349-B23","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.transproceed.2015.09.025","article-title":"Desensitization before living donor kidney transplantation in highly HLA-sensitized patients: a single centerstudy","volume":"47","author":"De Sousa-Amorim","year":"2015","journal-title":"Transplant Proc"},{"key":"2019110402561336900_gfy349-B24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.transproceed.2013.01.081","article-title":"Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients","volume":"45","author":"Al Meshari","year":"2013","journal-title":"Transplant Proc"},{"key":"2019110402561336900_gfy349-B25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-0039.2009.01283.x","article-title":"Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants","volume":"74","author":"Billen","year":"2009","journal-title":"Tissue Antigens"},{"key":"2019110402561336900_gfy349-B26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s11255-012-0169-1","article-title":"Kidney transplantation after desensitization in sensitized patients: a Korean National Audit","volume":"44","author":"Huh","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"2019110402561336900_gfy349-B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/tri.12199","article-title":"Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor KT recipients after desensitization therapy","volume":"27","author":"Chung","year":"2014","journal-title":"Transplant Int"},{"key":"2019110402561336900_gfy349-B28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplantations with a positive crossmatch","volume":"13","author":"Bentall","year":"2013","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trim.2008.09.013","article-title":"Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation","volume":"20","author":"Ho","year":"2008","journal-title":"Transplant Immunol"},{"key":"2019110402561336900_gfy349-B30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trim.2015.01.002","article-title":"Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation","volume":"32","author":"Malheiro","year":"2015","journal-title":"Transplant Immunol"},{"key":"2019110402561336900_gfy349-B31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/0886022X.2014.991997","article-title":"Pre-transplant low level HLA antibody shows a composite poor outcome in long-term outcome of renal transplant recipients","volume":"37","author":"Tian","year":"2015","journal-title":"Ren Fail"},{"key":"2019110402561336900_gfy349-B32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.TP.0000440954.14510.6a","article-title":"Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation","volume":"97","author":"Tsapepas","year":"2014","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B33","first-page":"40","article-title":"Luminex-based virtual crossmatching for renal transplantation in South Africa","volume":"102","author":"Worsley","year":"2011","journal-title":"S Afr Med J"},{"key":"2019110402561336900_gfy349-B34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.humimm.2013.06.022","article-title":"Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches","volume":"74","author":"Yamanaga","year":"2013","journal-title":"Hum Immunol"},{"key":"2019110402561336900_gfy349-B35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/TP.0000000000000191","article-title":"Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies","volume":"98","author":"Marfo","year":"2014","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B36","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B37","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.humimm.2012.07.320","article-title":"Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients","volume":"73","author":"Ling","year":"2012","journal-title":"Hum Immunol"},{"key":"2019110402561336900_gfy349-B38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.humimm.2010.01.003","article-title":"Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation","volume":"71","author":"Morris","year":"2010","journal-title":"Hum Immunol"},{"key":"2019110402561336900_gfy349-B39","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.transproceed.2012.09.084","article-title":"C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between LuminexSAB-C1q and SAB-IgG","volume":"44","author":"Llorente","year":"2012","journal-title":"Transplant Proc"},{"key":"2019110402561336900_gfy349-B40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/tri.12000","article-title":"Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients","volume":"26","author":"Bartel","year":"2013","journal-title":"Transplant Int"},{"key":"2019110402561336900_gfy349-B41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e3182100f77","article-title":"No association of kidney graft loss with human. No association of kidney human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report","volume":"91","author":"S\u00fcsal","year":"2011","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/TP.0000000000000821","article-title":"Deleterious impact of donor-specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation","volume":"100","author":"Bachelet","year":"2016","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B43","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pre-transplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B44","article-title":"Comparison of two Luminex single-antigen bead flow cytometry assays for detection of donor specific antibodies after renal transplantation","author":"Bertrand","year":"2018","journal-title":"Transplantation"},{"key":"2019110402561336900_gfy349-B45","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1111\/ajt.12463","article-title":"Solid-phase bead-based assays limitations are not restricted to inter-laboratory variability","volume":"13","author":"Maillard","year":"2013","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ajcp\/aqw116","article-title":"EDTA treatment of serum unmasks complement-mediated prozone inhibition in humanleukocyte antigen antibody testing","volume":"146","author":"Anani","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"2019110402561336900_gfy349-B47","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.humimm.2013.06.035","article-title":"Antibodies against denatured HLA class II molecules detected in Luminex-single antigen assay","volume":"74","author":"Grenzi","year":"2013","journal-title":"Hum Immunol"},{"key":"2019110402561336900_gfy349-B48","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/ajt.12807","article-title":"HLA antibody detection with solid phase assays: great expectations or expectations too great?","volume":"14","author":"Gebel","year":"2014","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B49","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2215\/CJN.02940311","article-title":"Incompatible live-donor kidney transplantation in the United States: results of a national survey","volume":"6","author":"Garonzik Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019110402561336900_gfy349-B50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2007.01667.x","article-title":"Pre-transplant risk assessment in renal allograft recipients using virtual crossmatching","volume":"7","author":"Bielmann","year":"2007","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am J Transplant"},{"key":"2019110402561336900_gfy349-B52","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1097\/TXD.0000000000000570","article-title":"Early and sustained reduction in donor-specific antibodies in desensitized living donor kidney transplant recipients: a 3-year prospective study","volume":"2","author":"Shaffer","year":"2016","journal-title":"Transplant Direct"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/11\/1950\/30335775\/gfy349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/11\/1950\/30335775\/gfy349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T19:53:02Z","timestamp":1662234782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/11\/1950\/5224803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,30]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy349","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2018,11,30]]}}}